AWM
PPH icon

Axxcess Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Axxcess Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Sell
9,553
-18
-0.2% -$1.86K 0.02% 521
2026
Q1 		$994K Sell
9,571
-314
-3% -$33.5K 0.03% 241
2025
Q4 		$1.02M Buy
9,885
+841
+9% +$81.8K 0.02% 508
2025
Q3 		$817K Sell
9,044
-70
-0.8% -$6.13K 0.02% 493
2025
Q2 		$802K Buy
9,114
+416
+5% +$36.1K 0.02% 482
2025
Q1 		$793K Buy
8,698
+3,985
+85% +$359K 0.02% 447
2024
Q4 		$407K Sell
4,713
-4,974
-51% -$450K 0.01% 595
2024
Q3 		$921K Sell
9,687
-356
-4% -$33.8K 0.02% 404
2024
Q2 		$919K Sell
10,043
-196
-2% -$17.5K 0.02% 389
2024
Q1 		$929K Sell
10,239
-1,394
-12% -$122K 0.03% 388
2023
Q4 		$947K Sell
11,633
-506
-4% -$39.7K 0.03% 370
2023
Q3 		$969K Hold
12,139
– – 0.03% 326
2023
Q2 		$956K Buy
12,139
+161
+1% +$12.6K 0.07% 237
2023
Q1 		$930K Buy
11,978
+8
+0.1% +$617 0.07% 245
2022
Q4 		$931K Hold
11,970
– – 0.08% 235
2022
Q3 		$805K Sell
11,970
-420
-3% -$30.9K 0.08% 222
2022
Q2 		$952K Hold
12,390
– – 0.09% 194
2022
Q1 		$988K Hold
12,390
– – 0.08% 215
2021
Q4 		$954K Buy
+12,390
New +$921K 0.07% 218

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Axxcess Wealth Management's PPH Position: Q2 2026 in Review

Axxcess Wealth Management reduced its VanEck Pharmaceutical ETF (PPH) stake by 0.19% in Q2 2026, selling an estimated $1.86K and leaving 9,553 shares worth $1.04M. The position accounts for 0.02% of the portfolio, ranked #521.

Axxcess Wealth Management first reported a position in PPH in Q4 2021 and has held it in 19 quarters since. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Axxcess Wealth Management held 9,553 shares of VanEck Pharmaceutical ETF worth $1.04M as of Q2 2026.
  • Axxcess Wealth Management sold 18 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $1.86K.
  • VanEck Pharmaceutical ETF made up 0.02% of Axxcess Wealth Management's portfolio in Q2 2026, its #521 holding.
  • Axxcess Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q4 2021 and has held it in 19 quarters since.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Axxcess Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.